Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for CycD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CycD participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 3 | 0 | 4 | 2 | 1 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
cycle | 85 | Network | Growth, CELLDIV, Rb_grp, IE_GRP, CycB_Grp, Cdc20_Grp, Cdh1_grp, E2F, CycA_Grp, CycE_grp, Early_Response_Genes, Delayed_Response_Genes, CycD_Grp |
| This is a fairly complete mass-action reimplementation of the Novak and Tyson mammalian cell cycle model. It is inexact on two counts. First, it replaces many rather abstracted equations with mass action and Michaelis-Menten forms of enzymes. Second, it does not handle the halving of cellular volume at the division point. Within these limitations, the model does most of what the original paper shows including oscillation of the relevant molecules. | |||
CycD acting as a Molecule in Mammalian_cell_cycle Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered |
| CycD | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0 | 200 | No |
CycD acting as an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | CycD / k20_lambdaD | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3300 | 4 | explicit E-S complex | Substrate Rb Product Rb_P |
| With a low Km, rate ~ kcat. Here we have rate = k20 * lambda_d = 10 * 3.3 = 33. 7 Apr 2005. Actually should have the substrate term in here. Use the form Km >> substrate, so rate = kcat * sub * enz / Km so kcat = Km * k20 * lambda_d = 10 * 10 * 3.3 = 330 | ||||||||
| 2 | CycD / k20_lambdaD[1] | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3300 | 4 | explicit E-S complex | Substrate E2FAP.Rb Product E2FAP Rb_P |
| With a low Km, rate ~ kcat. Here we have rate = k20 * lambda_d = 10 * 3.3 = 33. 7 Apr 2005. Actually should have the substrate term in here. Use the form Km >> substrate, so rate = kcat * sub * enz / Km so kcat = Km * k20 * lambda_d = 10 * 10 * 3.3 = 330 The idea here is that these reactions phosphorylate the Rb protein attached to E2FAP, so that Rb_P is released and E2FAP is left. | ||||||||
| 3 | CycD / k20_lambdaD[2] | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100 | 3300 | 4 | explicit E-S complex | Substrate E2FA.Rb Product E2FA Rb_P |
| With a low Km, rate ~ kcat. Here we have rate = k20 * lambda_d = 10 * 3.3 = 33. 7 Apr 2005. Actually should have the substrate term in here. Use the form Km >> substrate, so rate = kcat * sub * enz / Km so kcat = Km * k20 * lambda_d = 10 * 10 * 3.3 = 330 The idea here is that these reactions phosphorylate the Rb protein attached to E2FA, so that Rb_P is released and E2FA is left. | ||||||||
CycD acting as a Product of an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | CycE / k6_D_etaE | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| Rate = V6 * [CycD_Kip1]. k3.k1/k2 = rate = k6 * etaE = 50. 6 Apr 2005. Old rates in explicit form were k1 = 500, k2 = 10, k3 = 1. Need to go back to MM form because the above explict rates give a very low Km, ie, lots of E.S complex. k6 = 100, etaE = 0.5, Let Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaE = 500. | ||||||||
| 2 | CycA / k6_D_etaA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| k3.k1/k2 = k6.etaA = 100*0.5 = 50 Also k3 << k2. Assume ratio is 10. Let k3 be reasonable, say 1. Then k2 = 10, k1 = 500. 6 April 2005: The above rates are bad because they give a very low Km and too much E.S. complex. So, back to MM: Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaA = 10 * 100 * 0.5 = 500. | ||||||||
| 3 | CycB / k6_D_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| 6 Apr 2005. Earlier used explicit E.S complex form with k1 = 1000, k2 = 10, k3 = 1. This gave low Km and lots of E.S. complex. So shift to MM form: k6 = 100, etaB = 1. Let Km = 10 >> substrate. Then kcat = Km * k6 * etaB = 1000 | ||||||||
| 4 | DRG / k9 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 1.00002 | 5 | 4 | explicit E-S complex | Substrate AminoAcids Product CycD |
| Represented simply as [DRG]*k9, where k9 is 2.5. As AAs are at 1, we get rate = [AAs].[DRG].kcat / (Km + [AAs]) So if we set Km = [AAs] = 1, then kcat = 5 gives our desired equation. | ||||||||
CycD acting as a Substrate in a reaction in Mammalian_cell_cycle Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | k10 | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 5 (s^-1) | 0 (s^-1) | - | - | Substrate CycD Product degraded |
| 2 | k24 | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 999.996 (uM^-1 s^-1) | 10 (s^-1) | Kd(bf) = 0.01(uM) | - | Substrate CycD Kip1 Product CycD_Kip1 |
| k24 = 1000 k24r = 10 | ||||||||
CycD acting as a Product in a reaction in Mammalian_cell_cycle Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| k_prime6 | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 10 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycD_Kip1 Product CycD degraded |
color.